EyePoint Pharmaceuticals, Inc. (EYPT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.34B |
| Enterprise Value | 1.26B |
| P/E Ratio | -0.12 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 13.01 |
| Price/Book Ratio | 0.23 |
| Enterprise/Revenue | -18.57 |
| Enterprise/EBITDA | 0.18 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -109.95 |
| Operating Margin | -113.65 |
AD
Management Effectiveness
| Return On Assets | -1.34 |
| Return On Equity | -1.36 |
Income Statement
| Revenue | 31.37M |
| Revenue/Share | 0.03 |
| Gross Profit | 29.31M |
| EBITDA | -229.34M |
| Net Income | -231.96M |
| Diluted EPS | -3.17 |
Balance Sheet
| Total Cash | 180.47M |
| Total Cash/Share | 2.09 |
| Total Debt | 22.37M |
| Total Debt/Equity | 0.13 |
| Current Ratio | 4.5 |
| Book Value Per Share | 1.92 |
Price History
| 52-Week Change | -96.22 |
| 52-Week High | 19.11 |
| 52-Week Low | 0.39 |
| Moving Average 50 Days | 4.43 |
| Moving Average 200 Days | 11.55 |
Statistics
| Average Volume | 8.18M |
| Shares Outstanding | 83.84M |
| % Held by Institutions | 108.01 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | December 09, 2020 |
AD
